Eva Muehlhofer

Rivaroxaban versus Enoxaparin for Thromboprophylaxis after Hip Arthroplasty

Bengt I. Eriksson, Lars C. Borris, Richard J. Friedman et al. · New England Journal of Medicine · 2008 · 1.4K citations · Full text

Medicine, Orthopaedic Surgery, Pharmacology +15

Rivaroxaban in Peripheral Artery Disease after Revascularization

Marc P. Bonaca, Rupert Bauersachs, Sonia S. Anand et al. · New England Journal of Medicine · 2020 · 980 citations · Full text

Medicine, Pharmacotherapy, Surgery +15

Safety of Proton Pump Inhibitors Based on a Large, Multi-Year, Randomized Trial of Patients Receiving Rivaroxaban or Aspirin

Paul Moayyedi, John W. Eikelboom, Jackie Bosch et al. · Gastroenterology · 2019 · 477 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +7

A Once-Daily, Oral, Direct Factor Xa Inhibitor, Rivaroxaban (BAY 59-7939), for Thromboprophylaxis After Total Hip Replacement

Bengt I. Eriksson, Lars C. Borris, Ola E. Dahl et al. · Circulation · 2006 · 332 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Pantoprazole to Prevent Gastroduodenal Events in Patients Receiving Rivaroxaban and/or Aspirin in a Randomized, Double-Blind, Placebo-Controlled Trial

Paul Moayyedi, John W. Eikelboom, Jackie Bosch et al. · Gastroenterology · 2019 · 154 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +4